deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 2-arm NCT04024878

NeoVax With Nivolumab in Patients With Ovarian Cancer

Sponsor: Dana-Farber Cancer Institute

Conditions Ovarian Cancer
Interventions Core Needle Biopsy NeoVax Nivolumab
Updated 13 times since 2019 Last updated: Jun 16, 2025 Started: Nov 20, 2020 Primary completion: Apr 30, 2025 Completion: Apr 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Ovarian Cancer and is currently ongoing. Dana-Farber Cancer Institute leads this study, which shows 13 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2019 – ~Apr 2020 · 8 months · monthly snapshot~Apr 2020 – ~Aug 2020 · 4 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Sep 2023 · 12 months · monthly snapshot~Sep 2023 – ~Jun 2024 · 9 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshot~Jul 2025 – present · 12 months · monthly snapshot

Change History

13 versions recorded

  1. Jul 2025 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Sep 2024 — Jul 2025 [monthly]

    Active Not Recruiting PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

  4. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Sep 2023 — Jun 2024 [monthly]

    Recruiting PHASE1

▶ Show 8 earlier versions

  1. Sep 2022 — Sep 2023 [monthly]

    Recruiting PHASE1

  2. Sep 2021 — Sep 2022 [monthly]

    Recruiting PHASE1

  3. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  4. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE1

  6. Aug 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE1

  7. Apr 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE1

  8. Aug 2019 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dana-Farber Cancer Institute
  • United States Department of Defense
Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations